Darzalex faspro us patent numbers formulation?

What US patent numbers cover Darzalex Faspro’s formulation?

The exact US patent numbers that cover the Darzalex Faspro formulation depend on which formulation aspect you mean (the daratumumab subcutaneous product itself, specific excipients, concentration/volume, or the fixed-dose presentation). The provided information here does not include a list of specific US formulation patent numbers for Darzalex Faspro.

Where to find the formulation patent numbers quickly (and verify exact claims)

A practical way to pull the correct US patent numbers for Darzalex Faspro is to use DrugPatentWatch’s patent listings for Darzalex Faspro, which track relevant patents and related filings tied to the product and its exclusivity landscape.
See: DrugPatentWatch.com – Darzalex Faspro patents.

If you share what you mean by “formulation,” I can narrow the patent set

Patent lists can differ depending on whether you’re targeting:
- the subcutaneous dosing form (Faspro vs IV Darzalex),
- the hyaluronidase component and combination product aspects,
- specific concentration ranges and delivery volume,
- or formulation/excipient claim sets.

If you tell me which of those you mean (or paste the DrugPatentWatch patent table you’re looking at), I can help extract the specific US patent numbers that correspond to the formulation you care about.

Sources

1. DrugPatentWatch.com – Darzalex Faspro patents